{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:54:16Z","timestamp":1790610856609,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We investigated the relationship between cumulative, historical antibiotic therapy and the presence of ceftriaxone-resistant (CRO-R) Enterobacterales bloodstream infections (BSI) from urinary sources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult patients established with primary care at Mayo Clinic with a first episode of monomicrobial Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, or Proteus mirabilis BSI from a urinary source from May 2019 to May 2023 were included. Antibiotic therapy over the year prior to BSI was quantified as days of therapy (DOT), cumulative modified Antibiotic Spectrum Index (mASI), and cumulative Days of Antibiotic Spectrum Coverage (DASC) using prescription data. Patients with CRO-R urinary pathogens prior to antibiotic therapy assessment were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 721 adults had monomicrobial gram-negative BSI, including 70 patients (9.7%) with a CRO-R pathogen and 651 patients (90.3%) with a ceftriaxone-susceptible (CRO-S) pathogen. In the 12 months prior to BSI, levels of antibiotic DOT, mASI, and DASC were significantly greater among patients with CRO-R BSI than CRO-S BSI (P &amp;lt; .001). The median time from blood culture collection to appropriate antibiotic therapy was significantly longer in the CRO-R group (24\u2005hours, interquartile range [IQR] 16\u201348) than the CRO-S group (1\u2005hour, IQR 0\u20132) (P &amp;lt; .001). Increasing cumulative antibiotic therapy prior to BSI, as quantified by the mASI, was significantly associated with increased risk of 1-year CDI after BSI (P = .027).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with first episode CRO-R Enterobacterales BSI had significantly greater prior antibiotic exposure than patients with CRO-S BSI and experienced significant delay of appropriate therapy. Routine quantitation and reporting of prior antibiotic therapy may improve empiric prescribing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf315","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:46:57Z","timestamp":1749887217000},"page":"871-878","source":"Crossref","is-referenced-by-count":8,"title":["Cumulative Antibiotic Exposure Is Associated With Ceftriaxone Resistance Among Patients With Urinary Source Gram-negative Bloodstream Infection: A Retrospective Cohort Study"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9775-7082","authenticated-orcid":false,"given":"Aaron J","family":"Tande","sequence":"first","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5050-6689","authenticated-orcid":false,"given":"Ryan W","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-3901","authenticated-orcid":false,"given":"Dan","family":"Ilges","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Mayo Clinic Arizona , Phoenix, Arizona ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D","family":"Lahr","sequence":"additional","affiliation":[{"name":"Department of Biomedical Statistics and Informatics, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-9639","authenticated-orcid":false,"given":"Douglas W","family":"Challener","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2025122403232546000_ciaf315-B1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jinf.2010.01.007","article-title":"Bacteremia complicating gram-negative urinary tract infections: a population-based study","volume":"60","author":"Al-Hasan","year":"2010","journal-title":"J Infect"},{"key":"2025122403232546000_ciaf315-B2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/cid\/ciae253","article-title":"Preventing new gram-negative resistance through beta-lactam de-escalation in hospitalized patients with sepsis: a retrospective cohort study","volume":"79","author":"Teshome","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025122403232546000_ciaf315-B3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ajic.2012.11.010","article-title":"Microbiologic isolates and risk factors associated with antimicrobial resistance in patients admitted to the intensive care unit in a tertiary care hospital","volume":"41","author":"da Silva Winter","year":"2013","journal-title":"Am J Infect Control"},{"key":"2025122403232546000_ciaf315-B4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmi.2020.10.016","article-title":"Risk factors for carbapenem-resistant gram-negative bacterial infections: a systematic review","volume":"27","author":"Palacios-Baena","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025122403232546000_ciaf315-B5","doi-asserted-by":"crossref","first-page":"e0006321","DOI":"10.1128\/AAC.00063-21","article-title":"A pragmatic machine learning model to predict carbapenem resistance","volume":"65","author":"McGuire","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2025122403232546000_ciaf315-B6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/ciad189","article-title":"A broad spectrum of possibilities: spectrum scores as a unifying metric of antibiotic utilization","volume":"77","author":"Ilges","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025122403232546000_ciaf315-B7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1017\/ice.2017.94","article-title":"Development and application of an antibiotic Spectrum Index for benchmarking antibiotic selection patterns across hospitals","volume":"38","author":"Gerber","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025122403232546000_ciaf315-B8","doi-asserted-by":"crossref","first-page":"ofab508","DOI":"10.1093\/ofid\/ofab508","article-title":"Assessment of antibiotic de-escalation by spectrum score in patients with nosocomial pneumonia: a single-center, retrospective cohort study","volume":"8","author":"Ilges","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025122403232546000_ciaf315-B9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/cid\/ciab1034","article-title":"Days of antibiotic spectrum coverage: a novel metric for inpatient antibiotic consumption","volume":"75","author":"Kakiuchi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025122403232546000_ciaf315-B10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/677633","article-title":"Development of an antibiotic spectrum score based on veterans affairs culture and susceptibility data for the purpose of measuring antibiotic de-escalation: a modified Delphi approach","volume":"35","author":"Madaras-Kelly","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025122403232546000_ciaf315-B11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/ice.2022.151","article-title":"Measuring empiric antibiotic spectrum\u2014a journey through space and time","volume":"44","author":"Yarrington","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025122403232546000_ciaf315-B12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2025122403232546000_ciaf315-B13","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2025122403232546000_ciaf315-B14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.21105\/joss.00648","article-title":"Comorbidity: an R package for computing comorbidity scores","volume":"3","author":"Gasparini","year":"2018","journal-title":"J Open Source Software"},{"key":"2025122403232546000_ciaf315-B15","doi-asserted-by":"crossref","first-page":"ofz364","DOI":"10.1093\/ofid\/ofz364","article-title":"Oral fluoroquinolone or trimethoprim-sulfamethoxazole vs. Ss-lactams as step-down therapy for Enterobacteriaceae bacteremia: systematic review and meta-analysis","volume":"6","author":"Punjabi","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025122403232546000_ciaf315-B16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"key":"2025122403232546000_ciaf315-B17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025122403232546000_ciaf315-B18","doi-asserted-by":"crossref","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"key":"2025122403232546000_ciaf315-B19","doi-asserted-by":"crossref","first-page":"104942","DOI":"10.1016\/j.idnow.2024.104942","article-title":"Individual health insurance data of antibiotic delivery in previous months as a tool to predict bacterial resistance of urinary tract infection: a prospective cohort study","volume":"54","author":"Alexandre","year":"2024","journal-title":"Infect Dis Now"},{"key":"2025122403232546000_ciaf315-B20","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/cid\/ciae259","article-title":"Influence of antibiotic exposure intensity on the risk of Clostridioides difficile infection","volume":"79","author":"Ray","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025122403232546000_ciaf315-B21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1186\/s12879-022-07768-7","article-title":"E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community","volume":"22","author":"McCowan","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025122403232546000_ciaf315-B22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jac\/dkv338","article-title":"Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans healthcare administration","volume":"71","author":"Madaras-Kelly","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2025122403232546000_ciaf315-B23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/cid\/ciac727","article-title":"Association between time to appropriate antimicrobial treatment and 30-day mortality in patients with bloodstream infections: a retrospective cohort study","volume":"76","author":"Van Heuverswyn","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025122403232546000_ciaf315-B24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.2024.6259","article-title":"Stewardship prompts to improve antibiotic selection for urinary tract infection: the INSPIRE randomized clinical trial","volume":"331","author":"Gohil","year":"2024","journal-title":"JAMA"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf315\/63496659\/ciaf315.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/871\/63496659\/ciaf315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/871\/63496659\/ciaf315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:23:35Z","timestamp":1766564615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/5\/871\/8163478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6,16]]},"published-print":{"date-parts":[[2025,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf315","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,15]]},"published":{"date-parts":[[2025,6,16]]}}}